Publikationsliste
Kamp M.A., Knipps J., Steiger H.J., Rapp M., Cornelius J.F., Folke-Sabel S., Sabel M.: Training for
brain tumour resection: a realistic model with easy accessibility. Acta NC. 2015 Sep 26.(IF
1,52)
Ringel F., Pape H., Meyer B., Ringel F., Simon M., Sabel M., Rapp M., Krex D., Bock H.C., Rohde V.,
Weyerbrock A., Machein M.R., Westermaier T., Ernestus R.I., Franz K., Senft C., Schucht P.,
Beck J., Misch M., Vajkoczy P., Salehi M., Nievas M.C., Höllerhage H.G., Schneider T., TapiaPerez H., Höllig A., Clusmann H., Aumann W., Kretschmer T., Seiz-Rosenhagen M., Thomé
C., Buchalla R., Groß C., Stockhammer F., Radovanovic I., Schaller K., Wolf P.: Clinical
benefit from resection of recurrent glioblastomas: results of a multicenter study including 503
patients with recurrent glioblastomas undergoing surgical resection. Neuro Oncol. 2015 Aug 4.
pii: nov145. (IF 6,77)
Kamp M., Rapp M°., Bühner J., Slotty P.J., Reichelt D., Sadat H., Dibué-Adjei M., Steiger H.J.,
Turowski B., Sabel M.: Early postoperative magnet resonance tomography after resection of
cerebral metastases. Acta NC 2015 Sep;157(9):1573-80 (IF 1,52)
Galldiks N., Stoffels G., Filss C., Rapp M., Blau T., Tscherpel C., Ceccon G., Veronika Dunkl V.,
Weinzierl M., Stoffel M., Sabel M., Fink G.R., Shah N.J., Langen K.-J.: The use of dynamic O(2-18F-fluoroethyl)-L-tyrosine PET in the diagnosis of patients with progressive and recurrent
glioma. Neuro-Oncology, May 2015 (IF 5,28)
--------------------------------------------------------------------------------------------------------------Kamp M., Rapp M°., Slotty P.J., Turowski B., Sadat H., Smuga M., Dibué-Adjei M., Steiger H.-J.
Szelényi A., Sabel M.: Incidence of local in-brain progression
after supramarginal resection
of cerebral metastases. Acta NC, March 2015 (IF 1,52)
Kamp M., Felsberg J., Sadat H., Kuzibaev J., Steiger H.-J., Rapp M., Reifenberger G., Dibué M.,
Sabel M.: 5-ALA-induced fluorescence behavior of reactive tissue changes following
glioblastoma treatment with radiation and chemotherapy. Acta NC, Feb 2015 (IF 1,52)
Rapp M., Sadat H., Slotty P., Steiger H.-J., Budach W., Sabel M.: Feasibility of the EORTC/NCIC trial
protocol in a neurosurgical outpatient unit: the case for Neurosurgical Neurooncology. Cen Eur
Neurosurg., Apr 27, 2015 (IF 0,83)
Galldiks N., Dunkl V., Stoffels G., Hutterer M., Rapp M., Sabel M., Reifenberger G., Kebir S., Dorn F.,
Blau T., Herrlinger U., Hau P., Ruge MI., Kocher M., Goldbrunner R., Fink GR., Drzezga A.,
Schmidt M., Langen KJ.: Diagnosis of pseudoprogression in patients with glioblastoma using
O-(2-[18F]fluoroethyl)-L-tyrosine PET. Eur J Nucl Med Mol Imaging., Nov 20, 2014 (IF 5.217)
Hamilton J.D., Rapp M., Schneiderhahn M., Sabel M., Hayman A., Scherer A., Kröpil P., Budach W,
Kretschmar U, Arne Gerber P, Prabhu S, Ginsberg LE, Bölke E, Matuschek C.: Glioblastoma
Multiforme Metastasis Outside the CNS: Three Case Reports and Possible Mechanisms of
Escape. J Clin Oncol., Feb 24, 2014 (IF 18,038)
Langen K.J., Rapp M., Galldiks N., Reifenberger G., Floeth FW.: Reply: Discriminating Ability of 18FFET PET for Several Cerebral Neoplastic Lesions, J Nucl Med., Nov 6, 2013 (IF 6,38)
Galldiks N., Stoffels G., Ruge M., Rapp M., Sabel M., Reifenberger G., Erdem Z., Shah N., Fink G.,
Coenen H., Langen K.: Role of O-(2-18F-Fluoroethyl)-L-Tyrosine PET as a Diagnostic Tool for
Detection of Malignant Progression in Patients
with Low-Grade Glioma, J Nucl Med., Oct 54,
2013 (IF 6,38)
Rapp M., Kamp M., Steiger H.J., Sabel M.: Endoscopic assisted visualisation of 5-ALA induced
fluorescence in malignant glioma surgery- a technical note, Jul 2013, World of Neurosurgery
(IF 0,68)
Galldiks N., Rapp. M., Stoffels G., Dunkl V., Sabel M., Langen KJ.: Earlier diagnosis of progressive
disease during bevacizumab treatment using O-(2-18F- Fluorethyl)-L-tyrosine Positron
Emission Tomography in comparison with magnetic resonance imaging, Mol imaging, Aug
1;12(5) (IF 3,16)
Kamp M., Dibué M., Santacroce A., Zella S, Niemann L., Steiger H.J., Rapp M. and Sabel M.:The
tumour is not enough or is it? Problems and new concepts in the surgery of cerebral
metastases, ecancer Apr., 7:306, 2013
Rapp M., Goeppert M., Felsberg J. , Steiger HJ. , Sabel M.: The impact of sequential vs. combined
radiochemotherapy with temozolomide, resection and MGMT promoter hypermethylation on
survival of patients with primary glioblastoma- a single centre retrospective study, British J
Neurosurg (IF 0,88)
Rapp M., Floeth F., Steiger H.J., Sabel M., Langen K.J, Galldiks N.: Clinical Value of
18F-Fluoroethyl-
L-Tyrosine Positron- Emission Tomography (FET PET) in Low-Grade Glioma - Neurosurg
Focus, Feb;34(2), 2013 (IF 2,34)
Rapp M., Heinzel A., Galldiks N., Stoffels G., Felsberg J., Ewelt C., Sabel M., Steiger H.J,
Reifenberger G., Beez T., Coenen H., Floeth F., Langen K.J.: Diagnostic performance of
18F-
FET PET in newly diagnosed cerebral lesions with suspicion of glioma, J Nucl Med.,
Feb;54(2), 2013 (IF 6,38)
Rapp M., Rapp M., C. Berg C., Knoepfle G., Bartmann P., Mueller A.: Prenatal diagnosis and clinical
outcome of kaposiform hemangioendothelioma in siblings, Klinische Pädiatrie Okt 6, 2012 (IF
1,77)
2
Abdulazim A., Zella S., Rapp, M., Gierga K., Langen K.J., Steiger H.J, Sabel M:
Meningioangiomatosis in a patient with progressive focal neurological deficit- case report and
review of literature, Br J Neurosurg., Nov 20, 2012 (IF 0,88)
Galldiks N., Rapp M., Stoffels G., Fink GR., Shah NJ., Coenen HH., Sabel M., Langen K-J. :
Response assessment of bevacizumab in patients with recurrent malignant glioma using [18F]
Fluoroethyl-L-tyrosine PET in comparison to MRI, Eur J Nucl Med Mol Imaging Sept. 29, 2012
(IF 4,99)
Kamp M., Dibue M., Szelenyi A., Reichelt D.C, Felsberg J., Steiger H.J., Rapp M., Sabel M. Proof of
principle: Supramarginal resection of cerebral metastases in eloquent brain areas, Acta NC,
Nov 11, 2012 (IF 1,52)
Rapp M., Klingenhöfer M., Felsberg J., Steiger H.J., Stummer W., Sabel M. Fluorescence-Guided
Resection of Spinal Metastases of Malignant Glioma – Report of 2 Cases, Cen Eur Neurosurg.
Mar 10, 2011 (IF 0,83)
Rapp M., Felsberg J, Sorg RV, Gerharz C.D, Sabel M. Case report: extracranial metastasis from
gliosarcoma – the influence of immune system, Br J Neurosurg. Dec 15, 2010 (IF 0,88)
Ewelt C., Goeppert M., Rapp M., Steiger H.J., Stummer W., Sabel M. Glioblastoma multiforme of the
elderly: the prognostic effect of resection on survival, J Neurooncol. Oct 16, 2010 (IF 2,92)
Ringelstein A, Turowski B, Gizewski ER, Schroeteler J, Rapp M., Saleh A, Lanzman RS, Mathys C,
Sabel M, Mödder U. Evaluation of ADC Mapping as an Early Predictor for Tumor Response to
Chemotherapy in Recurrent Glioma Treated with Bevacizumab/Irinotecan: Proof of Principle,
Rofo. Aug 25, 2010 (IF 2,47)
Wick W., Hartmann C., Engel C., Stoffels M., Felsberg J., Stockhammer F., Sabel M. C., Koeppen S.,
Ketter R., Meyermann R., Rapp M., Meisner C., Kortmann R. D., Pietsch T., Wiestler O. D.,
Ernemann U., Bamberg M., Reifenberger G., von Deimling A., Weller M. NOA-04 Randomized
Phase III Trial of Sequential Radiochemotherapy of Anaplastic Glioma With Procarbazine,
Lomustine, and Vincristine or Temozolomide, J Clin Oncol, Nov 9, 2009 (IF 17,79)
Hänggi D., Eicker S., Beseoglu K., Rapp M., Perrin J., Nawatny J., Turowski B., Sommer C., Steiger
H. J. Dose-related efficacy of a continuous intracisternal nimodipine treatment on cerebral
vasospasm in the rat double subarachnoid hemorrhage model, Neurosurgery 64(6): 1155-9,
2009 (IF 2,86)
Felsberg J., Rapp M., Loeser S., Fimmers R., Stummer W., Goeppert M., Steiger H. J., Friedensdorf
B., Reifenberger G., Sabel M.C Prognostic Significance of Molecular Markers and Extent of
3
Resection in Primary Glioblastoma Patients, Clin Cancer Res; 15(21) November 1, 2009 (IF
6,74)
De Vleeschouwer S., Rapp M., Sorg R.V., Steiger H.J., Stummer W., van Gool S., Sabel M. Dendritic
cell vaccination in patients with malignant gliomas: current status and future directions,
Neurosurgery 59 (5), 2006 (IF 4,69)
Rapp M., Özcan Z., Steiger H.J., Wernet P., Sabel M., Sorg R.V. Cellular immunity of patients with
malignant glioma: prerequisites for dendritic cell vaccination immunotherapy, J Neurosurg
105:41–50, 2006 (IF 2,36)
Schellhammer F., Rapp M., Saleh A. Melorheostose der HWS bei einem intraspinalen Lipom Fortschr
Röntgenstr; 178: 816–823, 2006 (IF 1,76)
Sabel M., Rommel F., Kondakci M., Gorol M., Willers R., Bilzer T. Locoregional Opening of the
Rodent Blood–Brain Barrier for Paclitaxel Using Nd:YAG Laser-Induced Thermo Therapy: A
New Concept of Adjuvant Glioma Therapy? Lasers in Surgery and Medicine 33:75–80, 2003
(IF 2,74)
Sabel M., Rommel F., Kondakci M., Gorol M., Willers R., Bilzer T. Laser Induced Thermotherapy and
Blood-Brain-Barrier Changes: A Review, Medical Laser Application, März 2002 (IF)
insg. 63,38 IF
10 Erstautoren- Paper (18,47 IF)
21 Coautoren- Paper (54,91 IF)
nach PD:
Erstautoren Paper:
Co-Shared Erstautoren: 1 (1,52 IF)
Coautoren Paper: 3 (12,77 IF)
4
Veröffentlichte Abstracts:
Schroeteler J., Ringelstein A., Rapp M., Stoffels G., Langen K.J., Sabel M. MRI and FET-PET
demonstrate early response to Bevacizumab and Irinotecan Therapy in Recurrent Malignant
Glioma, Neuro-oncol 10 (5):326, 2008
Kriese Y., Rapp M., Ewelt C., Stummer W., Steiger H. J. , Sabel M. The cost of living: Quality of
life in glioblastoma patients, Neuro-oncol 10 (5): 326, 2008
Rapp, M., Sabel, M. , Özcan, Z., Fischer, J., Rox, J., Sorg, R. V. Immunotherapy of Glioblastoma
with Autologous Dendritic Cells, Neuro-oncol 10 (5): 326, 2008
Sabel M., Loeser S., Luyken C., Willers R., Rapp M., Reifenberger G. The prognostic value of
MGMT promoter hypermethylation and other genetic markers in malignant glioma patients
treated with temozolomide, Neuro-oncol 8 (4): 326, 2006
Loeser S.C., Blaschke B., Köhler S., Kreuzmann A., Rapp M., Goeppert M., Reifenberger G.,
Sabel M. Prognostic value of MGMT methylation and expression in malignant glioma patients
treated with adjuvant temozolomide chemotherapy, Acta Neuropathologica 112 (3): 375, 2006
Trampe-Kieslich A., El-Khatoutti A., Rapp M., Kögler G., Wernet P., Trapp T., Sabel M.,
Reifenberger G. Migration of somatic stem cells from umbilical cord blood towards glioma
cells, Acta Neuropathologica 112 (3): 375, 2006
5